Statement Of Unitholders' Equity

SymBio Pharmaceuticals Limited - Filing #7272884

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of unitholders' equity
Statement of unitholders' equity
Net assets
316,758,000 JPY
316,758,000 JPY
-89,863,000 JPY
-89,863,000 JPY
18,311,713,000 JPY
18,306,841,000 JPY
18,336,841,000 JPY
18,311,713,000 JPY
7,894,000 JPY
4,197,560,000 JPY
4,872,000 JPY
-32,794,671,000 JPY
3,764,020,000 JPY
-32,685,784,000 JPY
-32,794,671,000 JPY
4,080,779,000 JPY
18,336,841,000 JPY
3,872,907,000 JPY
7,894,000 JPY
277,044,000 JPY
277,044,000 JPY
17,952,692,000 JPY
-28,852,303,000 JPY
-28,871,032,000 JPY
6,920,120,000 JPY
17,922,692,000 JPY
17,927,584,000 JPY
-89,122,000 JPY
-28,871,032,000 JPY
-89,122,000 JPY
-5,985,000 JPY
7,209,909,000 JPY
4,891,000 JPY
17,952,692,000 JPY
6,938,849,000 JPY
-5,985,000 JPY
17,927,584,000 JPY
7,197,165,000 JPY
411,672,000 JPY
243,000 JPY
-88,154,000 JPY
243,000 JPY
8,506,092,000 JPY
-26,884,309,000 JPY
-88,154,000 JPY
17,548,459,000 JPY
17,548,459,000 JPY
-26,884,309,000 JPY
4,898,000 JPY
8,094,176,000 JPY
8,511,025,000 JPY
17,523,357,000 JPY
17,518,459,000 JPY
17,523,357,000 JPY
8,099,352,000 JPY
-26,889,486,000 JPY
411,672,000 JPY
Changes during period
Net changes in items other than shareholders' equity
39,713,000 JPY
13,879,000 JPY
39,713,000 JPY
53,593,000 JPY
13,879,000 JPY
39,713,000 JPY
-134,627,000 JPY
-134,627,000 JPY
-6,228,000 JPY
-140,856,000 JPY
-6,228,000 JPY
-134,627,000 JPY
Total changes during period
39,713,000 JPY
384,149,000 JPY
-3,156,100,000 JPY
384,129,000 JPY
13,879,000 JPY
-740,000 JPY
-740,000 JPY
-19,000 JPY
-3,116,386,000 JPY
-3,012,348,000 JPY
-3,065,942,000 JPY
384,149,000 JPY
13,879,000 JPY
384,149,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
384,129,000 JPY
39,713,000 JPY
-134,627,000 JPY
-134,627,000 JPY
-6,228,000 JPY
-1,296,183,000 JPY
-6,000 JPY
-1,986,723,000 JPY
-968,000 JPY
-6,228,000 JPY
-1,155,326,000 JPY
404,232,000 JPY
404,232,000 JPY
-1,986,723,000 JPY
404,232,000 JPY
-1,962,817,000 JPY
-1,179,232,000 JPY
404,226,000 JPY
-1,313,859,000 JPY
-968,000 JPY
404,226,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.